2008
DOI: 10.1007/s00417-008-0788-5
|View full text |Cite
|
Sign up to set email alerts
|

Phosphate concentration in ophthalmic corticoid preparations

Abstract: The phosphate concentration in corticoid-phosphate formulations varies greatly, and is mainly determined by the chosen buffer. The prednisolone acetate preparations showed physiological phosphate concentrations. For a treatment on a damaged corneal surface, preparations with physiological phosphate concentrations should be used.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…2006), fluorometholone (phosphorus content <0.1–22.5 mmol/l) and dexamethasone (phosphorus content 0.1–17.6 mmol/l) (Bernauer et al. 2008). Therefore, eyedrops with physiologic phosphate concentrations are recommended for patients with corneal defects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2006), fluorometholone (phosphorus content <0.1–22.5 mmol/l) and dexamethasone (phosphorus content 0.1–17.6 mmol/l) (Bernauer et al. 2008). Therefore, eyedrops with physiologic phosphate concentrations are recommended for patients with corneal defects.…”
Section: Discussionmentioning
confidence: 99%
“…The use of phosphate-containing eyedrops may increase the concentration of phosphate and promote the development of calcification (Taravella et al 1994;Anderson et al 2003;Bernauer et al 2006;Schrage et al 2010). In this study, three types of phosphate-containing eyedrops were commonly used for all patients after LKP: 0.3% sodium hyaluronate (Biolan, Santen, phosphorus content 2.1 mmol/l) (Bernauer et al 2006), fluorometholone (phosphorus content <0.1-22.5 mmol/l) and dexamethasone (phosphorus content 0.1-17.6 mmol/l) (Bernauer et al 2008). Therefore, eyedrops with physiologic phosphate concentrations are recommended for patients with corneal defects.…”
Section: Discussionmentioning
confidence: 99%
“…1 Phosphate, a commonly used buffer, is a vehicle with high buffering capacity that stabilizes the pH level at 7.4, and can also be found in some formulations as part of the active ingredient. 1,3,4 In addition, it has the added advantage of making corticosteroid-containing solutions more transparent. 3…”
Section: Introductionmentioning
confidence: 99%